Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction

Journal of Cardiac Failure

Volumn 10, Issue 5, 2004, Pages 433-441

  Masson, Serge ^a   Staszewsky, Lidia ^a   Annoni, Giorgio ^b   Carlo, Eleonora ^a   Arosio, Beatrice ^c   Bai, Antonio ^a   Caeabresi, Carmen ^c   Martinoli, Elena ^a   Salio, Monica ^a   Fiordaliso, Fabio ^a   Scanziani, Eugenio ^c   Rudolph, Amy E ^d   Latini, Roberto ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d PFIZER INC   (United States)

Author keywords

Aging; Aldosterone; Aorta; Diastolic function; Echocardiography; Myocardial infarction

Indexed keywords

ALDOSTERONE ANTAGONIST; EPLERENONE; GELATINASE; DRUG DERIVATIVE; SPIRONOLACTONE;

AGING; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIASTOLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HEART INFARCTION; HEMODYNAMICS; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RELAXATION TIME; STATISTICAL ANALYSIS; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECT; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME; WISTAR RAT;

ALDOSTERONE ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; AORTA; DIASTOLE; ECHOCARDIOGRAPHY; HEMODYNAMIC PROCESSES; KIDNEY; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; SPIRONOLACTONE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 21044435617     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.02.010     Document Type: Article

References (38)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003;107:346-54.
2. Lakatta EG, Sollott SJ. Perspectives on mammalian cardiovascular aging : humans to molecules. Comp Biochem Physiol Part A 2002; 132: 699-721.
3. Benjamin EJ, Levy D, Anderson KM, Wolf PA, Plehn JF, Evans JC, et al. Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol 1992;70:508-15.
4. Gardin JM, Arnold AM, Bild DE, Smith VE, Lima JAC, Klopfenstein HS, et al. Left ventricular diastolic finding in the elderly: the Cardiovascular Health Study. Am J Cardiol 1998;82:345-51.
5. Brenner DA, Apstein CS, Saupe KW. Exercise training attenuates age-associated diastolic dysfunction in rats. Circulation 2001;104:221-6.
6. Forman DE, Cittadini A, Azhar G, Douglas PS, Wei JY. Cardiac morphology and function in senescent rats: gender-related differences. J Am Coll Cardiol 1997;30:1872-7.
7. Pitt B, Zannad F, Remme WJ, Martinez F, Lopez-Sendon J, Zannad F, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med 1999;341:709-17.
8. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 2003; 348:1309-21.
9. Delcayre C, Swynghedauw B. Molecular mechanisms of myocardial remodeling: the role of aldosterone. J Molec Cell Cardiol 2002;34: 1577-84.
10. Cheng W, Reiss K, Li P, Chun MJ, Kajstura J, Olivetti G, et al. Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fisher 344 rats. Circ Res 1996;78:536-46.
11. Liu L, Azhar G, Gao W, Zhang X, Wei JY. Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age associated differences. Am J Physiol 1998;275:R315-22.
12. Ratajczak P, Damy T, Heymes C, Oliviero P, Marotte F, Robidel E, et al. Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging after myocardial infarction in rat. Cardiovasc Res 2003;57:358-69.
13. Raya TE, Gabella M, Anderson P, Goldman S. Left ventricular function and remodeling after myocardial infarction in aging rats. Am J Physiol 1997;273:H2652-8.
14. 1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodelling in an experimental model of left ventricular dysfunction after coronary artery occlusion. J Cardiovasc Pharmacol 1999;34:321-6.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography by the American Society of Echocardiography Committee on Standards, subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
17. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 1986;58:26-37.
18. Masson S, Arosio B, Fiordaliso F, Gagliano N, Calvillo L, Santambrogio D, et al. Left ventricular response to β-adrenergic stimulation in aging rats. J Gerontol 2000;55A:B35-41.
19. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol 1994;267:R124-35.
20. Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, Bauersachs J. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. J Am Coll Cardiol 2003;42:1666-73.
21. Delyani JA, Robinson EL, Rudolph AE. Effect of a selective aldosterone receptor antagonist in myocardial infarction. Am J Physiol 2001;50: H647-54.
22. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998;273:4883-91.
23. Silvestre JS, Heymes C, Oubénaïssa A, Robert V, Aupetit-Faisant B, Carayon A, et al. Activation of cardiac aldosterone production in rat myocardial infarction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999;99:2694-701.
24. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, et al. Aldosterone production is activated in failing ventricle in humans. Circulation 2001;103:72-7.
25. 2+-ATPase. Circulation 2000;101:790-6.
26. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction. Circ Res 1991;68:856-69.
27. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991; 260:H1406-14.
28. 2 agonist and a β-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion. J Cardiovasc Pharmacol 1998;31:601-8.
29. Shivakumar K, Dostal DE, Boheler K, Baker KM, Lakatta EG. Differential response of cardiac fibroblasts from young adult and senescent rats to Ang II. Am J Physiol 2003;284:H1454-9.
30. Mays PK, McAnulty RJ, Campa JS, Laurent GJ. Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production. Biochem J 1991;276:307-13.
31. Ben Driss A, Devaux C, Henrion D, Duriez M, Thuilez C, Levy BI, et al. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 2000;101:2764-70.
32. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats. Effects of eplerenone. Circulation 2002;106:2848-53.
33. Lacolley P, Safar M, Lucet B, Ledulal K, Labat C, Benetos A. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol 2001;37:662-7.
34. Cittadini A, Casaburi C, Monti MG, Di Gianni A, Serpico R, Scherillo G, et al. Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure. Cardiovasc Drugs Ther 2002;16:195-201.
35. Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, et al. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 2002;106:2967-72.
36. Jalil JE, Doering CW, Janicki JS, Pick R, Schroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64:1041-50.
37. Robert V, Besse S, Sabri A, Silvestre JS, Assayag P, Nbuyen VT, et al. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab Invest 1997;76:729-38.
38. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol 2002;283:H1802-10.